HCPCS Code Details - G9033

HCPCS Level II Code
Procedures/Professional Services (Temporary Codes)
HCPCS Code G9033
Description

Long description:
Amantadine hydrochloride, oral brand, per 100 mg (for use in a medicare-approved demonstration project)

Short description:
Amantadine hcl oral brand

HCPCS Modifier1
HCPCS Pricing indicator 13 - Clinical Lab Fee Schedule - Price established by carriers (e.g., not otherwise classified, individual determination, carrier discretion)
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
BETOS2 code O1E - Other drugs
HCPCS Action code D - Discontinue procedure or modifier code
Type of service 1 - Medical care
Effective date Effective Jan 01, 2020
Date added Added Dec 01, 2004
Termination date Dec 31, 2019
HCPCS Coding Procedures
  HCPCS Code G9033 has been discontinued effective Jan 01, 2020.

HCPCS Modifiers

In HCPCS Level II, modifiers are composed of two alpha or alphanumeric characters.

Example: E0260-NU - Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress
NU” identifies the hospital bed as new equipment

See also

  • HCPCS G9020 · Rimantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project)

  • HCPCS G9017 · Amantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project)

  • HCPCS G9034 · Zanamivir, inhalation powder, administered through inhaler, brand, per 10 mg (for use in a medicare-approved demonstration project)


1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”